The Simple Western™ Approach to Vaccine and Clinical Protein Research
- Broadcast Date:
Thursday, October 4, 2012
1 pm ET, 10 am PT
REGISTRATION IS FREE
For full access to this content and other high value GENSelect content & services, please sign in or register for FREE below.
LEARN MORE about GENSelect.
ProteinSimple has introduced the Simple Western™, a novel capillary electrophoresis (CE) based immunodetection platform for protein separation and characterization. It addresses the major challenges that researchers face on a daily basis—unreliable data, delayed time to results, reduced productivity and, ultimately, more costly research programs. The Simple Western is a complete automated walk-away solution that is a gel-free, blot-free, and hands-free reinvention of the Western blot. Simon and Sally are the two instruments that run Simple Western assays. The platform combines capillary electrophoretic protein separation with chemiluminescent immunodetection within the capillary resulting in rapid, more precise protein identification and quantitation.
In this webinar, participants will describe a range of applications utilizing the Simple Western technology. These applications include (i) protein vaccine development, incorporating analysis of cell lysate samples from baculovirusinfected insect cells and (ii) identification and quantitation of tumor-associated proteins, focusing on key kinase inhibitor targets in precious clinical patient samples.
In This Webinar You Will Learn
- How the Simple Western platform integrates and automates all manual operations associated with Western blotting
- How the Simple Western automated platform can generate up to 96 assays in one experiment How to increase efficiency of analytical testing and guide process development more effectively using the Simple Western
- How to use multiple detection antibodies in one experiment to identify more proteins and generate quantitative results with the Simple Western
- How to analyze key cancer-associated proteins and potential drug targets in different protein kinase signaling pathways using the Simple Western
Who Should Attend
- Protein biochemists
- QC/QA scientists
- Therapeutics protein developers
- Molecular biologists
- Protein-based vaccine developers
- Oncology drug developers
- Research oncologists
A live Q&A session will follow the presentations,
offering you a chance to pose questions to our expert panelists.